Literature DB >> 11722409

Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients.

M Svaldi1, J Hirber, A I Lanthaler, O Mayr, S Faes, E Peer, M Mitterer.   

Abstract

Procalcitonin (PCT) has proven to be a very sensitive marker of sepsis for non-leucopenic patients. Little is known about its relevance in immunosuppressed and leucopenic adults. Four hundred and seventy-five PCT determinations were carried out in 73 haematological patients: on 221 occasions the white blood cell (WBC) count was < 1.0 x 10(9)/l and on 239 occasions it was > 1.0 x 10(9)/l leucocytes. Patients were classified as: non-systemic infected controls (n = 280), patients with bacteraemia (n = 32), sepsis (n = 30), severe sepsis (n = 3), septic shock (n = 3) and systemic inflammatory response syndrome (SIRS) (n = 62). When the WBC count was > 1.0 x 10(9)/l, gram-negative bacteria induced higher PCT levels (median 9.4 ng/ml) than gram-positives (median 1.4 ng/ml). In cases with a WBC < 1.0 x 10(9)/l, PCT levels were similar for gram-negative and gram-positive bacteria (1.1 ng/ml versus 0.85 ng/ml). Regardless of the leucocyte count, the median PCT level in bacteraemia cases always remained < 0.5 ng/ml. In heavily leucopenic situations, PCT levels were never > 2 ng/ml even in the sepsis and severe sepsis/septic shock groups, whereas a WBC count > 1.0 x 10(9)/l resulted in median PCT values of 4.1 ng/ml and 45 ng/ml respectively. The positive predictive value for sepsis (cut-off 2 ng/ml) was 93% in cases of WBC count > 1.0 x 10(9)/l, but only 66% in leucopenic conditions. The negative predictive value (cut-off 0.5 ng/ml) was 90% when the WBC count was > 1.0 x 10(9)/l and 63% in leucopenic conditions. Procalcitonin is an excellent sepsis marker with a high positive- and negative-predictive value in patients with WBC count > 1.0 x 10(9)/l, but it does not work satisfactorily below this leucocyte count.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722409     DOI: 10.1046/j.1365-2141.2001.03083.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  20 in total

1.  Procalcitonin in febrile neutropenia--timing is important.

Authors:  Ban Hock Tan; May Ee Png; Chin Pin Yeo; Gee Chuan Wong
Journal:  Support Care Cancer       Date:  2013-12-04       Impact factor: 3.603

2.  Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies.

Authors:  M von Lilienfeld-Toal; A Schneider; K Orlopp; C Hahn-Ast; A Glasmacher; F Stüber
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.603

3.  Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients.

Authors:  Pierre Emmanuel Charles; Frédéric Dalle; Serge Aho; Jean-Pierre Quenot; Jean-Marc Doise; Hervé Aube; Nils-Olivier Olsson; Bernard Blettery
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

4.  Author's response to 'procalcitonin in febrile neutropenia--timing is important'.

Authors:  Shin Ahn
Journal:  Support Care Cancer       Date:  2014-01-09       Impact factor: 3.603

5.  Diagnostic accuracy of lipopolysaccharide-binding protein for predicting bacteremia/clinical sepsis in children with febrile neutropenia: comparison with interleukin-6, procalcitonin, and C-reactive protein.

Authors:  Lidija Kitanovski; Janez Jazbec; Sergej Hojker; Metka Derganc
Journal:  Support Care Cancer       Date:  2013-09-21       Impact factor: 3.603

6.  Procalcitonin--a marker of invasive fungal infection?

Authors:  H J Dornbusch; V Strenger; R Kerbl; H Lackner; W Schwinger; P Sovinz; C Urban
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

7.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.

Authors:  Claudi S M Oude Nijhuis; Edo Vellenga; Simon M G J Daenen; Winette T A van der Graaf; Jourik A Gietema; Harry J M Groen; Willem A Kamps; Eveline S J M de Bont
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

9.  Procalcitonin and C-reactive protein in early diagnosis of sepsis caused by either Gram-negative or Gram-positive bacteria.

Authors:  H H Liu; M W Zhang; J B Guo; J Li; L Su
Journal:  Ir J Med Sci       Date:  2016-05-02       Impact factor: 1.568

Review 10.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.